A California-based biotech company turned heads on Wednesday after the company announced the closing of patient enrollment in the multiple ascending dose (MAD) and dose-ranging...

To read the full story on AllPennyStocks.com, click here.

Aridis Pharmaceuticals (NASDAQ:ARDS)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Aridis Pharmaceuticals Charts.
Aridis Pharmaceuticals (NASDAQ:ARDS)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Aridis Pharmaceuticals Charts.